Data on Herpes Zoster Virus Described by a Researcher at Graduate School of Medicine [Immune Response to an Adjuvanted Recombinant Zoster Vaccine in Japanese Patients with Rheumatoid Arthritis Receiving Upadacitinib (End Zoster-J Study): Study...].

Researchers at the Graduate School of Medicine in Osaka, Japan, have conducted a study on the immune response to an adjuvanted recombinant zoster vaccine in Japanese patients with rheumatoid arthritis (RA) receiving upadacitinib. The study aims to examine the effectiveness of the vaccine in this specific population. Despite limitations such as a small sample size and short observation period, the study provides evidence on the effectiveness and tolerability of the vaccine in Japanese patients with RA receiving upadacitinib. For more information, readers can refer to the Journal of Clinical Medicine. [Extracted from the article]